Germany
· Delayed Price · Currency is EUR BioNxt Solutions Statistics
Total Valuation
ETR:BXT has a market cap or net worth of EUR 33.07 million. The enterprise value is 36.58 million.
| Market Cap | 33.07M |
| Enterprise Value | 36.58M |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +14.30% |
| Shares Change (QoQ) | +2.98% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 108.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,186.03 |
| PB Ratio | -6.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.51 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.55 |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.69 |
| Interest Coverage | -5.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -255.97% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 72.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.91% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.91% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 47.18 |
| Average Volume (20 Days) | 19,977 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:BXT had revenue of EUR 27,880 and -4.30 million in losses. Loss per share was -0.04.
| Revenue | 27,880 |
| Gross Profit | 27,880 |
| Operating Income | -3.55M |
| Pretax Income | -4.30M |
| Net Income | -4.30M |
| EBITDA | -3.50M |
| EBIT | -3.55M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 53,132 in cash and 3.73 million in debt, giving a net cash position of -3.67 million.
| Cash & Cash Equivalents | 53,132 |
| Total Debt | 3.73M |
| Net Cash | -3.67M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -4.90M |
| Book Value Per Share | -0.04 |
| Working Capital | -5.19M |
Cash Flow
In the last 12 months, operating cash flow was -2.15 million and capital expenditures -55,961, giving a free cash flow of -2.21 million.
| Operating Cash Flow | -2.15M |
| Capital Expenditures | -55,961 |
| Free Cash Flow | -2.21M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -12,733.85% |
| Pretax Margin | -15,422.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ETR:BXT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.30% |
| Shareholder Yield | -14.30% |
| Earnings Yield | -13.00% |
| FCF Yield | -6.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ETR:BXT has an Altman Z-Score of -159.51. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -159.51 |
| Piotroski F-Score | n/a |